Viking Therapeutics (VKTX) released new ... new weight-loss drug alternatives to current market leaders like Wegovy, Zepbound ...

“I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections ...

The findings were recently published in the New England Journal of Medicine ... While it remains unclear precisely how these ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Dulaglutide is another GLP-1 injection available under the brand name Trulicity®. This medication is FDA-approved for type 2 diabetes but is sometimes prescribed off-label for weight loss.

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their ...

An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11 ... Novo and Lilly ...